202 related articles for article (PubMed ID: 33372872)
1. Chagas Disease and Coumarins: A Review of Natural and Synthetic Coumarins As Anti-Trypanosoma Cruzi Agents.
Gonçalves GA; Cerecetto H; Poser GLV; Canto RFS; Eifler-Lima VL
Mini Rev Med Chem; 2021; 21(13):1701-1717. PubMed ID: 33372872
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo trypanocidal activities of 8-methoxy-3-(4-nitrobenzoyl)-6-propyl-2H-cromen-2-one, a new synthetic coumarin of low cytotoxicity against mammalian cells.
Brancaglion GA; Toyota AE; Cardoso Machado JV; Fernandes Júnior AÁ; Silveira AT; Vilas Boas DF; Dos Santos EG; Caldas IS; Carvalho DT
Chem Biol Drug Des; 2018 Nov; 92(5):1888-1898. PubMed ID: 29992719
[TBL] [Abstract][Full Text] [Related]
3. Coumarins isolated from Calophyllum brasiliense produce ultrastructural alterations and affect in vitro infectivity of Trypanosoma cruzi.
Rodríguez-Hernández KD; Martínez I; Agredano-Moreno LT; Jiménez-García LF; Reyes-Chilpa R; Espinoza B
Phytomedicine; 2019 Aug; 61():152827. PubMed ID: 31039535
[TBL] [Abstract][Full Text] [Related]
4. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
Soares FGN; Göethel G; Kagami LP; das Neves GM; Sauer E; Birriel E; Varela J; Gonçalves IL; Von Poser G; González M; Kawano DF; Paula FR; de Melo EB; Garcia SC; Cerecetto H; Eifler-Lima VL
BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):76. PubMed ID: 31852548
[TBL] [Abstract][Full Text] [Related]
5. Natural and synthetic naphthoquinones active against Trypanosoma cruzi: an initial step towards new drugs for Chagas disease.
Salas CO; Faúndez M; Morello A; Maya JD; Tapia RA
Curr Med Chem; 2011; 18(1):144-61. PubMed ID: 21110810
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antioxidant and antichagasic properties of a selected series of hydroxy-3-arylcoumarins.
Robledo-O'Ryan N; Matos MJ; Vazquez-Rodriguez S; Santana L; Uriarte E; Moncada-Basualto M; Mura F; Lapier M; Maya JD; Olea-Azar C
Bioorg Med Chem; 2017 Jan; 25(2):621-632. PubMed ID: 27908757
[TBL] [Abstract][Full Text] [Related]
7. An insight on targets and patented drugs for chemotherapy of Chagas disease.
Duschak VG; Couto AS
Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):19-51. PubMed ID: 18221162
[TBL] [Abstract][Full Text] [Related]
8. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity.
Zingales B; Miles MA; Moraes CB; Luquetti A; Guhl F; Schijman AG; Ribeiro I; ;
Mem Inst Oswaldo Cruz; 2014 Sep; 109(6):828-33. PubMed ID: 25317712
[TBL] [Abstract][Full Text] [Related]
9. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
[TBL] [Abstract][Full Text] [Related]
10. Advances in Chagas disease drug development: 2009-2010.
Buckner FS; Navabi N
Curr Opin Infect Dis; 2010 Dec; 23(6):609-16. PubMed ID: 20885320
[TBL] [Abstract][Full Text] [Related]
11. Novel drug design for Chagas disease via targeting Trypanosoma cruzi tubulin: Homology modeling and binding pocket prediction on Trypanosoma cruzi tubulin polymerization inhibition by naphthoquinone derivatives.
Ogindo CO; Khraiwesh MH; George M; Brandy Y; Brandy N; Gugssa A; Ashraf M; Abbas M; Southerland WM; Lee CM; Bakare O; Fang Y
Bioorg Med Chem; 2016 Aug; 24(16):3849-55. PubMed ID: 27345756
[TBL] [Abstract][Full Text] [Related]
12. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
Beltran-Hortelano I; Perez-Silanes S; Galiano S
Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacology in the Treatment of Chagas Disease.
Aguilera E; Alvarez G; Cerecetto H; González M
Curr Med Chem; 2019; 26(23):4476-4489. PubMed ID: 29637852
[TBL] [Abstract][Full Text] [Related]
14. Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies.
Soeiro Mde N; Dantas AP; Daliry A; Silva CF; Batista DG; de Souza EM; Oliveira GM; Salomão K; Batista MM; Pacheco MG; Silva PB; Santa-Rita RM; Barreto RF; Boykin DW; Castro SL
Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():301-10. PubMed ID: 19753489
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents.
Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G
Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, molecular modelling, and in vitro evaluation of tricyclic coumarins against Trypanosoma cruzi.
Coelho GS; Andrade JS; Xavier VF; Sales Junior PA; Rodrigues de Araujo BC; Fonseca KDS; Caetano MS; Murta SMF; Vieira PM; Carneiro CM; Taylor JG
Chem Biol Drug Des; 2019 Mar; 93(3):337-350. PubMed ID: 30362274
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of novel
Espinoza-Chávez RM; Oliveira Rezende Júnior C; de Souza ML; Pauli I; Valli M; Gomes Ferreira LL; Chelucci RC; Michelan-Duarte S; Krogh R; Romualdo da Silva FB; Cruz FC; de Oliveira AS; Andricopulo AD; Dias LC
Future Med Chem; 2024 Feb; 16(3):253-269. PubMed ID: 38193294
[No Abstract] [Full Text] [Related]
18. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Image-Based Assay for Trypanosoma cruzi Intracellular Forms.
Eufrásio AG; Cordeiro AT
Methods Mol Biol; 2020; 2116():773-780. PubMed ID: 32221954
[TBL] [Abstract][Full Text] [Related]
20. Anti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds.
Cerecetto H; González M
Mini Rev Med Chem; 2008 Nov; 8(13):1355-83. PubMed ID: 18991753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
